
Oscar Health, Inc.: updates and filings
Price
$24.73
November 20, 2026Market cap $6.5B
What Ploutos Investor adds for Oscar Health
Part of Ploutos Investor, €9.99 a month
- The full history: 7 fiscal years, from 2019
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The share price has fallen 21% since Nov 5, 2026, when the 10-Q these figures come from was filed ($33.18 then, $26.17 on Nov 19, 2026). The figures date from before that move.10-Q
- Earnings per share here are the last twelve months' earnings over today's shares, so they agree with the P/E. The number of shares changed a lot during the year, so they differ from the earnings per share the company filed, which use the year's average number of shares.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 5, 2026next Feb 5, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
August 2026
May 2026
February 2026
December 2025
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 16, 2026Officer or director changeForm8-K
- Nov 5, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 5, 2026Results of operationsForm8-K
- Sep 18, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- Sep 16, 2026Regulation FD disclosureForm8-K
- Aug 7, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 6, 2026Results of operationsForm8-K
- Jun 9, 2026Shareholder voteForm8-K
- Jun 8, 2026Regulation FD disclosureForm8-K
- Jun 2, 2026Officer or director changeForm8-K
- May 7, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- May 6, 2026Results of operationsForm8-K
- Apr 22, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Apr 22, 2026Additional annual meeting materialFormDEFA14A
- Apr 22, 2026Annual meeting proxy statementFormDEF 14A
- Apr 21, 2026Regulation FD disclosureForm8-K
- Mar 27, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Mar 2, 2026Regulation FD disclosureForm8-K
- Feb 17, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Feb 13, 2026Shares registered for employeesFormS-8
- Feb 13, 2026Annual reportfor the period to Dec 31, 2025Form10-K
- Feb 10, 2026Material agreement entered, results of operations, new material financial obligationForm8-K
- Dec 29, 2025Officer or director changeForm8-K
- Nov 14, 2025Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 13, 2025Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 16, 2026 | 8-K | Officer or director change | Document |
| Nov 5, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 5, 2026 | 8-K | Results of operations | Document |
| Sep 18, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| Sep 16, 2026 | 8-K | Regulation FD disclosure | Document |
| Aug 7, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 6, 2026 | 8-K | Results of operations | Document |
| Jun 9, 2026 | 8-K | Shareholder vote | Document |
| Jun 8, 2026 | 8-K | Regulation FD disclosure | Document |
| Jun 2, 2026 | 8-K | Officer or director change | Document |
| May 7, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| May 6, 2026 | 8-K | Results of operations | Document |
| Apr 22, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Apr 22, 2026 | DEFA14A | Additional annual meeting material | Document |
| Apr 22, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Apr 21, 2026 | 8-K | Regulation FD disclosure | Document |
| Mar 27, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Mar 2, 2026 | 8-K | Regulation FD disclosure | Document |
| Feb 17, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Feb 13, 2026 | S-8 | Shares registered for employees | Document |
| Feb 13, 2026 | 10-K | Annual reportfor the period to Dec 31, 2025 | Document |
| Feb 10, 2026 | 8-K | Material agreement entered, results of operations, new material financial obligation | Document |
| Dec 29, 2025 | 8-K | Officer or director change | Document |
| Nov 14, 2025 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 13, 2025 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Sep 11, 2013.
The full analysis
What do Oscar Health's filings show?
The filings are where every one of Oscar Health's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.